title: Using a nonparametric multilevel latent Markov model to evaluate diagnostics for trachoma.
abstract: In disease control or elimination programs, diagnostics are essential for assessing the impact of interventions, refining treatment strategies, and minimizing the waste of scarce resources. Although high-performance tests are desirable, increased accuracy is frequently accompanied by a requirement for more elaborate infrastructure, which is often not feasible in the developing world. These challenges are pertinent to mapping, impact monitoring, and surveillance in trachoma elimination programs. To help inform rational design of diagnostics for trachoma elimination, we outline a nonparametric multilevel latent Markov modeling approach and apply it to 2 longitudinal cohort studies of trachoma-endemic communities in Tanzania (2000-2002) and The Gambia (2001-2002) to provide simultaneous inferences about the true population prevalence of Chlamydia trachomatis infection and disease and the sensitivity, specificity, and predictive values of 3 diagnostic tests for C. trachomatis infection. Estimates were obtained by using data collected before and after mass azithromycin administration. Such estimates are particularly important for trachoma because of the absence of a true "gold standard" diagnostic test for C. trachomatis. Estimated transition probabilities provide useful insights into key epidemiologic questions about the persistence of disease and the clearance of infection as well as the required frequency of surveillance in the post-elimination setting.
authors.forename: Artemis
authors.initials: A
authors.lastname: Koukounari
authors.forename: Irini
authors.initials: I
authors.lastname: Moustaki
authors.forename: Nicholas C
authors.initials: NC
authors.lastname: Grassly
authors.forename: Isobel M
authors.initials: IM
authors.lastname: Blake
authors.forename: María-Gloria
authors.initials: MG
authors.lastname: Basáñez
authors.forename: Manoj
authors.initials: M
authors.lastname: Gambhir
authors.forename: David C W
authors.initials: DC
authors.lastname: Mabey
authors.forename: Robin L
authors.initials: RL
authors.lastname: Bailey
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Burton
authors.forename: Anthony W
authors.initials: AW
authors.lastname: Solomon
authors.forename: Christl A
authors.initials: CA
authors.lastname: Donnelly
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D017963:Azithromycin / Q000008:administration & dosage*; D002692:Chlamydia trachomatis / Q000302:isolation & purification*; D060740:Disease Eradication / Q000379:methods*; D019353:Endemic Diseases / Q000517:prevention & control; D005714:Gambia / Q000453:epidemiology; D006801:Humans; D008137:Longitudinal Studies; D008390:Markov Chains; D008954:Models, Biological; D011159:Population Surveillance / Q000379:methods; D015995:Prevalence; D018709:Statistics, Nonparametric; D013636:Tanzania / Q000453:epidemiology; D014141:Trachoma / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D000900:Anti-Bacterial Agents; D017963:Azithromycin
keywords: diagnosis; latent Markov model; multilevel; nonparametric model; trachoma
references.citation: Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4215-22
references.pmid: 14507864
references.citation: Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):6012-7
references.pmid: 21693601
references.citation: Lancet. 1993 Aug 21;342(8869):453-6
references.pmid: 8102427
references.citation: PLoS Negl Trop Dis. 2008;2(12):e341
references.pmid: 19048024
references.citation: J Infect Dis. 2003 May 15;187(10):1669-73
references.pmid: 12721948
references.citation: PLoS Negl Trop Dis. 2010 Nov 02;4(11):e862
references.pmid: 21072225
references.citation: Stat Methods Med Res. 2008 Feb;17(1):33-51
references.pmid: 17855746
references.citation: Invest Ophthalmol Vis Sci. 2011 Aug 03;52(9):6133-7
references.pmid: 21685340
references.citation: PLoS Negl Trop Dis. 2009;3(3):e401
references.pmid: 19333364
references.citation: Br J Ophthalmol. 2007 Mar;91(3):293-5
references.pmid: 17050583
references.citation: Drug Alcohol Depend. 2002 Nov;68 Suppl 1:S85-96
references.pmid: 12324177
references.citation: Stat Methods Med Res. 2008 Feb;17(1):5-32
references.pmid: 17855748
references.citation: Ophthalmic Epidemiol. 2004 Jul;11(3):255-62
references.pmid: 15370556
references.citation: Struct Equ Modeling. 2010 Apr 1;17(2):193-215
references.pmid: 21057651
references.citation: Am J Trop Med Hyg. 2010 Mar;82(3):482-7
references.pmid: 20207878
references.citation: Multivariate Behav Res. 2008 Apr-Jun;43(2):289-326
references.pmid: 26765664
references.citation: Biometrics. 1997 Sep;53(3):948-58
references.pmid: 9290225
references.citation: Lancet. 2005 Apr 9-15;365(9467):1321-8
references.pmid: 15823382
references.citation: PLoS Negl Trop Dis. 2009 Dec 22;3(12):e573
references.pmid: 20027217
references.citation: Nat Rev Microbiol. 2010 Dec;8(12 Suppl):S17-29
references.pmid: 21548184
references.citation: Invest Ophthalmol Vis Sci. 1989 Aug;30(8):1823-33
references.pmid: 2668220
references.citation: J Infect Dis. 1994 Sep;170(3):709-12
references.pmid: 8077735
references.citation: Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):235-40
references.pmid: 22159017
references.citation: Biometrics. 2000 Sep;56(3):733-41
references.pmid: 10985209
references.citation: N Engl J Med. 2004 Nov 4;351(19):1962-71
references.pmid: 15525721
references.citation: Clin Microbiol Rev. 2004 Oct;17(4):982-1011, table of contents
references.pmid: 15489358
references.citation: Stat Med. 2002 Jan 15;21(1):113-28
references.pmid: 11782054
references.citation: Multivariate Behav Res. 1998 Oct 1;33(4):457-78
references.pmid: 26753825
references.citation: Lancet. 2003 Jul 19;362(9379):198-204
references.pmid: 12885481
references.citation: Stat Med. 1986 Jan-Feb;5(1):21-7
references.pmid: 3961312
references.citation: Bull World Health Organ. 1987;65(4):477-83
references.pmid: 3500800
references.citation: Br J Ophthalmol. 2009 May;93(5):563-8
references.pmid: 19098034